The global astaxanthin market was valued at USD 2.34 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 17.1% from 2024 to 2030. This growth is largely driven by the increasing demand for astaxanthin across various sectors, including aquaculture, animal feed, nutraceuticals, cosmetics, pharmaceuticals, and food and beverages.

Astaxanthin is a powerful antioxidant commonly used as a food ingredient in the aquaculture industry, especially for species such as prawns, salmon, trout, and ornamental fish. It enhances the coloration of these aquatic animals, which in turn increases their commercial value. Beyond its cosmetic effects, astaxanthin offers several health benefits for aquatic species. It helps improve stress tolerance, promotes better growth, boosts immune-related gene expressions, supports reproductive capacity, enhances survival rates, and increases disease resistance. Due to these benefits, major companies are intensifying their focus on product development and forming collaborative agreements to cater to the growing demand for astaxanthin in aquaculture.

The astaxanthin market is also characterized by significant innovation, with companies developing new formulations and sustainable production methods to meet the evolving market needs. A notable example of such innovation is Sirio Europe (SIRIO), which, in August 2023, announced plans to introduce two new softgel products targeted at the pharmaceutical sector during the CPHI Barcelona 2023 event. These new products represent a step toward diversifying the application of astaxanthin in different industries.

Additionally, the market is seeing considerable merger and acquisition (M&A) activity among leading companies. In January 2022, ENEOS Corporation made a strategic acquisition of Ecocert Inputs Attestation, a globally recognized certification organization. This move strengthens ENEOS' position in the astaxanthin market, particularly for its product Panaferd-AX. The merger underscores ENEOS' commitment to maintaining high-quality standards and meeting international certifications, which further supports the growth of the astaxanthin market.

Gather more insights about the market drivers, restrains and growth of the Astaxanthin Market 

Regional Insights:

North America Astaxanthin Market Trends

North America is currently the largest market for astaxanthin, accounting for 36.53% of the global market share in 2023. The region’s demand for astaxanthin is largely driven by the rising prevalence of nutrition-related and skin-related health issues. Moreover, North America is home to major players such as Cyanotech, Piveg, Inc., and Beijing Ginko Group (BGG), as well as synthetic astaxanthin producers like Cardax, Inc.. These companies are expected to drive continued market growth throughout the forecast period. The region also benefits from a large consumer base that is increasingly health-conscious, coupled with a growing adoption of nutraceuticals and a well-established cosmeceutical industry. These factors collectively fuel the increasing demand for astaxanthin products in North America.

Asia Pacific Astaxanthin Market Trends

Asia Pacific, on the other hand, is expected to experience the fastest growth in the astaxanthin market over the forecast period. This growth is supported by increasing production capacities, higher research and development (R&D) expenditures, and strong economic growth in the region. Countries in the Asia Pacific are becoming key manufacturing hubs for astaxanthin, with several companies ramping up production to meet regional demand.

India

In India, the growing prominence of natural ingredients is contributing to the rising popularity of astaxanthin. For example, BodyFirst Wellness Nutrition, an Indian nutraceutical company, launched its range of products both nationwide and internationally after a successful market test. The company has already established a solid presence in North India through partnerships with 15 distributors. Its official launch aims for broader reach, including collaboration with 100 more distributors across India and expanding its global presence through online platforms. The launch highlights the increasing adoption of traditional, natural ingredients, such as ashwagandha and astaxanthin, in India’s burgeoning nutraceutical market.

Browse through Grand View Research's Category Pharmaceuticals Industry Research Reports.

• The global celiac disease treatment market size was valued at USD 582.5 million in 2023 and is projected to grow at a CAGR of 11.8% from 2024 to 2030.

• The global food allergy treatment market size was estimated at USD 6.87 billion in 2024 and is projected to grow at a CAGR of 8.27% from 2025 to 2030.

Key Companies & Market Share Insights:

The astaxanthin market features several key players, including Algatech Ltd., Cyanotech Corporation, and ALGAMO. These companies are enhancing their market positions by expanding into new geographical regions to increase their market share. Additionally, they are focusing on securing market approvals for innovative products aimed at addressing various health conditions.

Emerging players in the market are adopting strategies such as collaborations with research institutes and academic organizations to innovate and bring new products to market. These collaborations are helping to drive forward both product development and the establishment of new contracts, positioning these companies for future growth. Furthermore, the agility of emerging market players allows them to adapt quickly to changing market demands and technological advancements, making them more flexible than their larger, established counterparts.

Key Astaxanthin Companies:

• Algatech Ltd

• MicroA

• Cyanotech Corporation

• Algalíf Iceland ehf

• Beijing Gingko Group (BGG)

• PIVEG, Inc.

• Fuji Chemical Industries Co., Ltd

• ENEOS Corporation

• Atacama Bio Natural Products S.A.

• E.I.D. – Parry (India) Limited (Alimtec S.A., Valensa International)

Order a free sample PDF of the Astaxanthin Market Intelligence Study, published by Grand View Research.